These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Personalized medicine: how much can we afford? A bioethics perspective. Lunshof J Per Med; 2005 Mar; 2(1):43-47. PubMed ID: 29793239 [TBL] [Abstract][Full Text] [Related]
65. Personalized Medicine in a New Genomic Era: Ethical and Legal Aspects. Shoaib M; Rameez MAM; Hussain SA; Madadin M; Menezes RG Sci Eng Ethics; 2017 Aug; 23(4):1207-1212. PubMed ID: 27896605 [TBL] [Abstract][Full Text] [Related]
66. The new era of personalized medicine: 10 years later. Jørgensen JT; Winther H Per Med; 2009 Jul; 6(4):423-428. PubMed ID: 29783540 [TBL] [Abstract][Full Text] [Related]
67. The ethical framing of personalized medicine. Joly Y; Saulnier KM; Osien G; Knoppers BM Curr Opin Allergy Clin Immunol; 2014 Oct; 14(5):404-8. PubMed ID: 25054830 [TBL] [Abstract][Full Text] [Related]
68. The Impact of Pharmacogenomics in Personalized Medicine. Singh DB Adv Biochem Eng Biotechnol; 2020; 171():369-394. PubMed ID: 31485703 [TBL] [Abstract][Full Text] [Related]
69. Making preventive medicine more personalized: implications for exercise-related research. Buford TW; Pahor M Prev Med; 2012 Jul; 55(1):34-6. PubMed ID: 22588227 [TBL] [Abstract][Full Text] [Related]
70. Personalized medicine is more than genomic medicine: confusion over terminology impedes progress towards personalized healthcare. Simmons LA; Dinan MA; Robinson TJ; Snyderman R Per Med; 2012 Jan; 9(1):85-91. PubMed ID: 29783292 [TBL] [Abstract][Full Text] [Related]
71. Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research priorities. Conti R; Veenstra DL; Armstrong K; Lesko LJ; Grosse SD Med Decis Making; 2010; 30(3):328-40. PubMed ID: 20086232 [TBL] [Abstract][Full Text] [Related]
72. Computational challenges of personal genomics. Bolouri H Curr Genomics; 2008 Apr; 9(2):80-7. PubMed ID: 19440448 [TBL] [Abstract][Full Text] [Related]
73. Balancing personalized medicine and personalized care. Cornetta K; Brown CG Acad Med; 2013 Mar; 88(3):309-13. PubMed ID: 23348082 [TBL] [Abstract][Full Text] [Related]
74. Model-guided therapy for hepatocellular carcinoma: a role for information technology in predictive, preventive and personalized medicine. Berliner L; Lemke HU; vanSonnenberg E; Ashamalla H; Mattes MD; Dosik D; Hazin H; Shah S; Mohanty S; Verma S; Esposito G; Bargellini I; Battaglia V; Caramella D; Bartolozzi C; Morrison P EPMA J; 2014; 5(1):16. PubMed ID: 25538797 [TBL] [Abstract][Full Text] [Related]
75. Scientific-practical and legal problems of implementation of the personalized medicine. Bezdieniezhnykh NO; Reznikova VV; Rossylna OV Exp Oncol; 2017 Sep; 39(3):229-233. PubMed ID: 28967634 [TBL] [Abstract][Full Text] [Related]
78. [Personalized medicine, privatized medicine? legal and public health stakes]. Rial-Sebbag E Med Sci (Paris); 2014 Nov; 30 Spec No 2():36-40. PubMed ID: 25407457 [TBL] [Abstract][Full Text] [Related]
79. Personalized diagnostics and biosensors: a review of the biology and technology needed for personalized medicine. Ahmed MU; Saaem I; Wu PC; Brown AS Crit Rev Biotechnol; 2014 Jun; 34(2):180-96. PubMed ID: 23607309 [TBL] [Abstract][Full Text] [Related]
80. Personalized diagnostic and therapeutic strategies in oncology. Febbo PG; Ginsburg GS Per Med; 2005 May; 2(2):97-110. PubMed ID: 29788586 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]